IC
MDXG icon

Inscription Capital’s MiMedx Group MDXG Stock Holding History

Inscription Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,778
Closed -$62.3K – 836
2026
Q1 		$62.3K Buy
+15,778
New +$79.5K 0.01% 706

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Inscription Capital's MDXG Position: Q2 2026 in Review

Inscription Capital sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 15,778 shares — an estimated $62.3K sold.

Inscription Capital first reported a position in MDXG in Q1 2026 and held it in 1 quarter. The position peaked at $62.3K in Q1 2026. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Inscription Capital reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
  • Inscription Capital sold 15,778 MiMedx Group shares in Q2 2026, an estimated $62.3K.
  • Inscription Capital first reported a position in MiMedx Group in Q1 2026 and held it in 1 quarter.
  • Inscription Capital's MiMedx Group position peaked at $62.3K in Q1 2026.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.